PlainPharmaWatch

CMS Open Payments · Program Year 2024

Rhode Island

Rhode Island received $7,964,778.73 in pharmaceutical-industry payments to 2,416 physicians and 7 teaching hospitals across 48,468 transactions.

$8.0M
Total payments
$6.9M
To physicians
$191.9K
To teaching hospitals
#42
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $8.0M in payments to 2,416 physicians and 7 teaching hospitals in Rhode Island. That ranks Rhode Island #42 of 59 states and territories (0.1% of the US total), averaging $2.8K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Rhode Island pairs below-median payment volume with an overwhelmingly physician-directed payment mix.

#42
of 59 states
0.1%
of the national total
86.4%
to physicians vs. hospitals
2,416
physicians paid

What the Data Shows for Rhode Island

Rhode Island sits in the lower-volume tercile at #42 of 59 (0.1% of US dollars). The PY2024 file still records $7,964,778.73 across 48,468 transactions.

The distinctive cut versus volume is the physician share: 86.4% of dollars to 2,416 physicians ($2.8K each). Average transaction $164.33. Leading nature of payment: "Compensation for Services Other Than Consulting" at $2.0M (25.0% of the state file; top-three natures 61.2%).

Rhode Island sits in the 31st percentile (lower-volume tier). Just above: West Virginia ($8.3M). Just below: Puerto Rico ($7.5M). For context: top-ranked California ($342.4M) is 43.0× larger than Rhode Island. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Rhode Island are distributed between physicians and teaching hospitals.

Physician Payments

$6.9M

86.4% of total · 2,416 recipients · $2.8K avg

Teaching Hospital Payments

$191.9K

2.4% of total · 7 hospitals · $27.4K avg

Payment Breakdown by Type

Rhode Island has 15 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 25.0%.

Nature concentration in Rhode Island

Top three Open Payments natures are 61.2% of state dollars; residual is every other reported nature

Compensation for Services Ot…$2.0MConsulting Fee$1.6MFood and Beverage$1.3MAll other natures (12)$3.1M

Payment categories in Rhode Island

Top categories by total reported dollar volume

1. Compensation for Services…$2.0M2. Consulting Fee$1.6M3. Food and Beverage$1.3M4. Acquisitions$987.0K5. Royalty or License$735.5K6. Travel and Lodging$619.0K7. Grant$272.5K8. Compensation for Faculty …$175.7K9. Education$132.1K10. Honoraria$93.5K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $2.0M 777
Consulting Fee $1.6M 712
Food and Beverage $1.3M 44,281
Acquisitions $987.0K 4
Royalty or License $735.5K 49
Travel and Lodging $619.0K 1,888
Grant $272.5K 26
Compensation for Faculty or Speaker (Medical Education) $175.7K 86
Education $132.1K 472
Honoraria $93.5K 30
Space Rental or Facility Fees $30.0K 15
Long-Term Medical Supply or Device Loan $16.5K 17
Debt Forgiveness $16.4K 17
Gift $9.4K 85
Entertainment $891.70 9

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Rhode Island totals can and cannot tell you

The aggregate payment figure for Rhode Island measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Rhode Island's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.